Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The specificity and clinical relevance of nine antimitochondrial antibodies (AMA) - anti-M1 to anti-M9 - are described. All nine AMA types react with antigens which are associated either with inner (M1, M2, M7) our outer mitochondrial membranes (M3, M4, M5, M6, M8, M9) derived from rat liver or beef heart mitochondria. These antigens can be clearly distinguished by their different physical and chemical properties. Anti-M1 to anti-M9 can be related to distinct clinical entities: anti-M1, anti-M5, and anti-M7 are found in nonhepatic disorders, such as syphilis (anti-M1), undefined collagen diseases (anti-M5), and some forms of cardiac diseases (anti-M7). Anti-M3 and anti-M6 are detected in drug-induced disorders, such as phenopyrazon-induced pseudolupus syndrome (PLE; anti-M3) and iproniazid-induced hepatitis (anti-M6). Anti-M2, anti-M4, anti-M8, and anti-M9 are confined to primary biliary cirrhosis (PBC). Anti-M2 is a specific marker for the diagnosis of PBC; 96% of PBC patients (n = 752) were anti-M2 positive. Anti-M4 and anti-M8 seem to reflect disease activity. Anti-M9 antibodies occur preferentially in early PBC. The clinical course of PBC was analyzed with respect to four different AMA profiles: profile A: only anti-M9 positive in the ELISA; profile B: anti-M9 and anti-M2 positive in the ELISA; profile C: anti-M2 positive in ELISA and complement fixation test (CFT), but anti-M4 and anti-M8 positive only in the ELISA; and profile D: anti-M2, anti-M4, anti-M8 positive in EL…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nine of these anti-mitochondrial antibodies (AMA-M1 to AMA-M9) have been identified and named according to their specific characteristics (that is, the targets, pathological context of detection, appearance by indirect immunofluorescence (IIF), band labelling by western blot and ability to bind to complement)229–231.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [229]
In the citing paper
“AMA-M1 are a group of aCL antibodies that are directed solely towards cardiolipin229.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [229]
In the citing paper
“AMA profiling of patients with PBC has enabled researchers to improve both diagnosis and prognosis of the disease229,237.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [229]
In the citing paper
“Detection of AMA (i.e. AwMA, AmtDNA, AmtRNA. IgG and IgM) was performed by our research laboratory, as previously published (11)”
From Identification of Mitofusin 1 and Complement Component 1q Subcomponent Binding Protein as Mitochondrial Targets in Systemic Lupus Erythematosus (2022) · cites this paper as [11]
In the citing paper
“Antibodies targeting mitochondrial components other than mtDNA are also found in SLE. They include anti-cardiolipin [AMA-M1, also known as anti-cardiolipin antibodies (ACA)], anti-60kDa heat shock protein (anti-HSP60), as well as AMA-M3 and AMA-M5 antibodies.”
From Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations (2019) · cites this paper as [34]
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385 · cited 1×
“In contrast to the ELISA method, in the immunoblot method the reaction of antibodies with different antigenic determinants can be visualized [31].”
MethodRaza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
ENZYMATIC PROPERTIES OF THE INNER AND OUTER MEMBRANES OF RAT LIVER MITOCHONDRIA
Schnaitman, C., & Greenawalt, J. W. (1968) · The Journal of Cell Biology · doi:10.1083/jcb.38.1.158 · Cited by 1,386 · cited 1×
“Separating inner and outer mitochondrial membranes following the digitonin method of Schnaitman and Greenawalt [28], the M6-antigen copurified with the outer membrane fraction.”
BackgroundSEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS
WALKER, J. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91372-3 · Cited by 507 · cited 3×
“Anti-M2 sera give a very typical IFL pattern [32], showing a bright staining of renal distal tubules.”
BackgroundMethodChristensen, E., Crowe, J., Doniach, D., Popper, H., Ranek, L., Rodés, J., Tygstrup, N., & Williams, R. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90571-5 · Cited by 273 · cited 1×
“AMA have been found in more than 90% of patients with PBC and titers measured in IFL or CFT did not greatly vary when patients were followed for many years [8].”
BackgroundPRIMARY BILIARY CIRRHOSIS IS A DRY GLAND SYNDROME WITH FEATURES OF CHRONIC GRAFT-VERSUS-HOST DISEASE
Epstein, O., Thomas, H. C., & Sherlock, S. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91621-9 · Cited by 224 · cited 1×
“Thus, PBC was also described as a "dry gland syndrome" [ 9 ] affecting not only bile ducts but also ducts of the pancreas or salivary gland.”
BackgroundKoike, T., Sueishi, M., Funaki, H., Tomioka, H., & Yoshida, S. (1984) · PubMed · Cited by 192
Lindenborn-Fotinos, J., Baum, H., & Berg, P. A. (1985) · Hepatology · doi:10.1002/hep.1840050510 · Cited by 161
Self-citation(1984) · PubMed Central · Cited by 153
Self-citationBerg, P. A., Lindenborn-Fotinos, J., Klein, R., & Klöppel, W. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91327-7 · Cited by 144
Self-citationFrazer, I. H., Mackay, I. R., Jordan, T. W., Whittingham, S., & Marzuki, S. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.3.1739 · Cited by 137 · cited 1×
“ATPase subunits is involved in anti-M2 binding [10, 21].”
BackgroundAntimitochondrial antibodies in primary biliary cirrhosis
Berg, P. A., Klein, R., & Lindenborn-Fotinos, J. (1986) · Journal of Hepatology · doi:10.1016/s0168-8278(86)80015-0 · Cited by 124 · cited 2×
“Applying also the complement fixation test (CFT) or enzyme linked immunosorbent assay (ELISA) for the detection of AMA, nine AMA types - anti-M1 to anti-M9 - could be distinguished in the past 20 years [2].”
BackgroundMethodSelf-citationBerg, P. A., Sayers, T., Wiedmann, K. H., Klöppel, G., & Lindner, H. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92397-1 · Cited by 93 · cited 4×
“Thus, anti-M4 has been preferentially found in those patients who showed histologically typical features of PBC and CAH in parallel ("mixed form") [7].”
BackgroundMethodInfluentialSelf-citationMeek, F. L., Khoury, E. L., Doniach, D., & Baum, H. (1980) · PubMed · Cited by 81
(1978) · PubMed Central · Cited by 58
NEW ANTIBODY IN EARLY SYPHILIS
WRIGHT, D., Doniach, D., Lessof, M. H., Turk, J. L., Grimble, A. S., & Catterall, R. D. (1970) · The Lancet · doi:10.1016/s0140-6736(70)90972-4 · Cited by 58 · cited 3×
“Anti-M1 + / IFL, ELISA, CFT [34] Anti-M5 - / + IFL, ELISA, CFT [20] Anti-M7 + / -ELISA [16]”
BackgroundPreciitating antibodies to mitochondrial antigens in patients with primary biliary cirrhosis.
Miyachi, K., Gupta, R. C., Dickson, E. R., & Tan, E. M. (1980) · PubMed · Cited by 57
A new antimitochondria antibody (anti-M6) in iproniazid-induced hepatitis.
(1982) · PubMed Central · Cited by 53
Lindenborn-Fotinos, J., Sayers, T. J., & Berg, P. A. (1982) · PubMed · Cited by 52
Self-citationGrob, P. J., Häcki, M., Müller-Schoop, J., & Joller‐Jemelka, H. I. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90055-0 · Cited by 52 · cited 1×
“PLE syndrome in many respects resembles other LE-like syndromes which have been induced by drugs such as hydralazine or procainamide [5, 11, 23].”
Background(1979) · PubMed Central · Cited by 52
Self-citationWeber, P., Brenner, J., Stechemesser, E., Klein, R., Weckenmann, U., Klöppel, G., Kirchhof, M., Fintelmann, V., & Berg, P. A. (1986) · Hepatology · doi:10.1002/hep.1840060402 · Cited by 50
Self-citationEin Lupus-erythematodes-ähnliches Syndrom mit antimitochondrialen Antikörpern
Maas, D., & Schubothe, H. (1973) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1106763 · Cited by 47 · cited 1×
“PLE syndrome in many respects resembles other LE-like syndromes which have been induced by drugs such as hydralazine or procainamide [5, 11, 23].”
BackgroundBerg, P. A., Roitt, I. M., Doniach, D., & Cooper, H. M. (1969) · PubMed · Cited by 40
Self-citationSayers, T. J., Leoutsakos, A., Berg, P. A., & Baum, H. (1981) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00743204 · Cited by 36 · cited 1×
“Trypsin treatment also completely destroyed the M2 activity [27].”
BackgroundSelf-citationImmunologische Phänomene bei Leberkrankheiten: Die Bedeutung mitochondrialer Antikörper
Berg, P. A., Doniach, D., & Roitt, I. M. (1969) · Journal of Molecular Medicine · doi:10.1007/bf01484292 · Cited by 22
Self-citationKlein, R., Lindenborn-Fotinos, J., & Berg, P. A. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90401-5 · Cited by 18 · cited 1×
“tested by ELISA or fluorometric immunoassay 96% of patients with histologically and clinically well-defined PBC were shown to be positive (total tested, n=752) [6, 15].”
MethodSelf-citationSchultheiß, H., Berg, P. A., & Klingenberg, M. (1984) · PubMed · Cited by 18
Self-citationBerg, P. A., Traunecker, U., & Märker, A. (1973) · PubMed · Cited by 14
Self-citationImmunreaktionen beim Pseudo-Lupus-Syndrom: Eine Langzeitstudie
Schuff‐Werner, P., & Berg, P. A. (1980) · Journal of Molecular Medicine · doi:10.1007/bf01477051 · Cited by 7 · cited 1×
“In most patients anti-M3 became negative after withdrawal of the drug, but in some instances low titers persisted for many years [29].”
BackgroundSelf-citationAbstracts Submitted to the International Association for the Studv of the Liver
(1984) · Hepatology · doi:10.1002/hep.1840040438 · Cited by 5
Anti M9 — A marker antibody for early asymptomatic primary biliary cirrhosis (PBC)
(1985) · Journal of Hepatology · doi:10.1016/s0168-8278(85)80564-x · Cited by 2
(1985) · Journal of Hepatology · doi:10.1016/s0168-8278(85)80533-x · Cited by 1
Research works printed but not linked: 3
- Berg PA, Traunecker U, Märker A (1973) Mitochondriale Antikörper bei nicht hepatischen Krankheiten. Dtsch Med Wochenschr 98:1186–1188
- Berg PA, Weber P, Oehring J, Lindenborn-Fotinos J, Stechemesser E (1985) Significance of different types of mitochondrial antibodies in primary biliary cirrhosis. In: H Brunner, H Thaler (eds) Hepatology: A Festschrift für Hans Popper. Raven press, New York, pp 231–242
- Klein R, Schultheiß HP, Berg PA (1984) Nachweis von organspezifischen antimitochondrialen Antikörpern (Anti-M9) bei Patienten mit primär-biliärer Zirrhose. Verh Dtsch Ges Inn Med 90:910–913
Cited by
SZOSTECKI, C., WILL, H., NETTER, H. J., & GULDNER, H. H. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb03224.x · Cited by 364
Van de Water, J., Gershwin, M. E., Leung, P., Ansari, A., & Coppel, R. L. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.6.1791 · Cited by 279
Van de Water, J., Cooper, A., Surh, C. D., Coppel, R., Danner, D., Ansari, A., Dickson, R., & Gershwin, M. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905253202104 · Cited by 201
Autoantibodies in Heart Failure and Cardiac Dysfunction
Kaya, Z., Leib, C., & Katus, H. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.243360 · Cited by 187
Moteki, S., Leung, P. S., Coppel, R. L., Dickson, E. R., Kaplan, M. M., Munoz, S., & Gershwin, M. E. (1996) · Hepatology · doi:10.1002/hep.510240117 · Cited by 152
Metadata
- Authors
- Berg, P. A., & Klein, R.
- Affiliations
- Universitätsklinikum Tübingen (DE)
- ORCID
- Klein, R.
- Venue
- Klinische Wochenschrift
- Published
- 1986-10
- Volume
- 64
- Issue
- 19
- Pages
- 897-909
- ISSN
- 0946-2716 (ISSN-L)
- 0023-2173
- 1432-1440
- OpenAlex
- W2007048294
- Cited by
- 48
- References
- 33
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 3 · 2012: 2
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- antimitochondrial antibodies, anti-M2 antibodies, primary biliary cirrhosis, mitochondrial antigens, mitochondrial outer membrane, inner mitochondrial membrane, drug-induced liver injury, connective tissue diseases, syphilis, heart disease, disease activity markers, antibody profiles, cross-reactive antigens, complement fixation test
- MeSH terms
- Antibody Specificity, Autoantibodies, Autoantigens, Cardiolipins, Collagen Diseases, Fluorescent Antibody Technique, Humans, Liver Cirrhosis, Biliary, Lupus Erythematosus, Systemic, Mitochondria, Mitochondria, Liver, Cardiomyopathies, Myocarditis, Prognosis, Syphilis, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.